{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T10:16:43Z","timestamp":1768990603339,"version":"3.49.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.ecl.2006.05.003","type":"journal-article","created":{"date-parts":[[2007,1,10]],"date-time":"2007-01-10T10:08:25Z","timestamp":1168423705000},"page":"575-599","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Diabetic Cardiomyopathy"],"prefix":"10.1016","volume":"35","author":[{"given":"Gregg C.","family":"Fonarow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preethi","family":"Srikanthan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ecl.2006.05.003_bib1","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.CIR.93.5.841","article-title":"Report of the 1995 World Health Organization\/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies","volume":"93","author":"Richardson","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ecl.2006.05.003_bib2","series-title":"Heart failure: pathogenesis and treatment","author":"Narula","year":"2002"},{"key":"10.1016\/j.ecl.2006.05.003_bib3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJM199807233390404","article-title":"Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction","volume":"339","author":"Haffner","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ecl.2006.05.003_bib4","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/jama.1979.03290450033020","article-title":"Diabetes and cardiovascular disease: the Framingham study","volume":"241","author":"Kannel","year":"1979","journal-title":"JAMA"},{"key":"10.1016\/j.ecl.2006.05.003_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000064682","article-title":"Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy","volume":"98","author":"Schannwell","year":"2002","journal-title":"Cardiology"},{"key":"10.1016\/j.ecl.2006.05.003_bib6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2337\/diacare.24.1.5","article-title":"Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy","volume":"24","author":"Poirier","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ecl.2006.05.003_bib7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.euje.2005.03.009","article-title":"The BNP assay does not identify mild left ventricular diastolic dysfunction in asymptomatic diabetic patients","volume":"7","author":"Valle","year":"2006","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.ecl.2006.05.003_bib8","doi-asserted-by":"crossref","first-page":"708","DOI":"10.2337\/diacare.18.5.708","article-title":"Diabetic cardiomyopathy: a unique entity or a complication of coronary artery disease?","volume":"18","author":"Bell","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ecl.2006.05.003_bib9","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1161\/01.CIR.101.19.2271","article-title":"Impact of diabetes on cardiac structure and function: the strong heart study","volume":"101","author":"Devereux","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ecl.2006.05.003_bib10","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0735-1097(02)02869-3","article-title":"Echocardiographic detection of early diabetic myocardial disease","volume":"41","author":"Fang","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ecl.2006.05.003_bib11","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1042\/CS20030168","article-title":"Subclinical left ventricular dysfunction in asymptomatic patients with type II diabetes mellitus, related to serum lipids and glycated haemoglobin","volume":"105","author":"Vinereanu","year":"2003","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.ecl.2006.05.003_bib12","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0002-9343(55)90218-7","article-title":"Studies on myocardial metabolism: IV. myocardial metabolism in diabetes","volume":"18","author":"Ungar","year":"1955","journal-title":"Am J Med"},{"key":"10.1016\/j.ecl.2006.05.003_bib13","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1161\/01.CIR.0000013953.41667.09","article-title":"Prevention Conference VI: diabetes and cardiovascular disease. Writing Group I: epidemiology","volume":"105","author":"Howard","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ecl.2006.05.003_bib14","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ccl.2004.07.002","article-title":"Diabetes mellitus and heart failure: basic mechanisms, clinical features, and therapeutic considerations","volume":"22","author":"Giles","year":"2004","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.ecl.2006.05.003_bib15","doi-asserted-by":"crossref","first-page":"3G","DOI":"10.1016\/S0002-9149(02)02553-5","article-title":"Insulin resistance as the core defect in type 2 diabetes mellitus","volume":"90","author":"Goldstein","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ecl.2006.05.003_bib16","doi-asserted-by":"crossref","first-page":"624","DOI":"10.2337\/diacare.23.5.624","article-title":"Heart rate in relation to insulin sensitivity and insulin secretion in nondiabetic subjects","volume":"23","author":"Festa","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ecl.2006.05.003_bib17","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0002-8703(91)90970-S","article-title":"Pulse rate, coronary heart disease, and death: the NHANES I Epidemiologic Follow-up Study","volume":"121","author":"Gillum","year":"1991","journal-title":"Am Heart J"},{"key":"10.1016\/j.ecl.2006.05.003_bib18","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/0002-8703(87)90666-1","article-title":"Heart rate and cardiovascular mortality: the Framingham Study","volume":"113","author":"Kannel","year":"1987","journal-title":"Am Heart J"},{"key":"10.1016\/j.ecl.2006.05.003_bib19","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1161\/01.CIR.0000012466.50373.E8","article-title":"Adaptation and maladaptation of the heart in diabetes: Part I. general concepts","volume":"105","author":"Taegtmeyer","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ecl.2006.05.003_bib20","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1093\/oxfordjournals.eurheartj.a015067","article-title":"Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI Study Group. Diabetes Insulin-Glucose in Acute Myocardial Infarction","volume":"17","author":"Malmberg","year":"1996","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ecl.2006.05.003_bib21","series-title":"Molecular cell biology","first-page":"743","article-title":"Cellular genetics: formation of ATP by glycolysis and oxidative phosphorylation","author":"Darnell","year":"1990"},{"key":"10.1016\/j.ecl.2006.05.003_bib22","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1161\/01.CIR.92.8.2151","article-title":"Hyperinsulinemia inhibits myocardial protein degradation in patients with cardiovascular disease and insulin resistance","volume":"92","author":"McNulty","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.ecl.2006.05.003_bib23","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s11906-003-0028-7","article-title":"Insulin resistance and the sympathetic nervous system","volume":"5","author":"Egan","year":"2003","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.ecl.2006.05.003_bib24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0033-0620(98)80030-3","article-title":"Beta-adrenergic blockade in chronic heart failure: principles, progress, and practice","volume":"41","author":"Packer","year":"1998","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.ecl.2006.05.003_bib25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1385\/CT:5:3:285","article-title":"Cardiomyocyte dysfunction in models of type 1 and type 2 diabetes","volume":"5","author":"Ye","year":"2005","journal-title":"Cardiovasc Toxicol"},{"key":"10.1016\/j.ecl.2006.05.003_bib26","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.2337\/diacare.26.10.2949","article-title":"Diabetic cardiomyopathy","volume":"26","author":"Bell","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ecl.2006.05.003_bib27","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1161\/01.CIR.93.10.1905","article-title":"Aminoguanidine prevents the decreased myocardial compliance produced by streptozotocin-induced diabetes mellitus in rats","volume":"93","author":"Norton","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ecl.2006.05.003_bib28","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.2337\/diabetes.48.7.1443","article-title":"Effects of glucose intolerance on myocardial function and collagen-linked glycation","volume":"48","author":"Avendano","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.ecl.2006.05.003_bib29","doi-asserted-by":"crossref","first-page":"H2587","DOI":"10.1152\/ajpheart.00516.2003","article-title":"Glycation end-product cross-link breaker reduces collagen and improves cardiac function in aging diabetic heart","volume":"285","author":"Liu","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.ecl.2006.05.003_bib30","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJM198805193182007","article-title":"Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications","volume":"318","author":"Brownlee","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ecl.2006.05.003_bib31","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.RES.0000065620.39919.20","article-title":"A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes","volume":"92","author":"Candido","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.ecl.2006.05.003_bib32","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0008-6363(02)00513-8","article-title":"Correlation of functional and structural alterations of the coronary arterioles during development of type II diabetes mellitus in rats","volume":"56","author":"Yu","year":"2002","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ecl.2006.05.003_bib33","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/978-1-4615-1321-6_27","article-title":"Oxidative stress and functional deficit in diabetic cardiomyopathy","volume":"498","author":"Singal","year":"2001","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.ecl.2006.05.003_bib34","doi-asserted-by":"crossref","first-page":"174","DOI":"10.2337\/diabetes.51.1.174","article-title":"Overexpression of metallothionein reduces diabetic cardiomyopathy","volume":"51","author":"Liang","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.ecl.2006.05.003_bib35","first-page":"E798","article-title":"Changes in cardiac protein kinase C activities and isozymes in streptozotocin-induced diabetes","volume":"277","author":"Liu","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.ecl.2006.05.003_bib36","doi-asserted-by":"crossref","first-page":"H138","DOI":"10.1152\/ajpheart.2002.282.1.H138","article-title":"Left ventricular diastolic dysfunction in type 2 diabetes mellitus model rats","volume":"282","author":"Abe","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.ecl.2006.05.003_bib37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1023\/A:1006824623496","article-title":"Cardiac sarcolemmal Na(+)-Ca2+ exchange and Na(+)-K+ ATPase activities and gene expression in alloxan-induced diabetes in rats","volume":"188","author":"Golfman","year":"1998","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.ecl.2006.05.003_bib38","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1161\/01.CIR.99.22.2942","article-title":"Troglitazone inhibits voltage-dependent calcium currents in guinea pig cardiac myocytes","volume":"99","author":"Nakajima","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ecl.2006.05.003_bib39","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1046\/j.1440-1681.2002.03618.x","article-title":"A metabolic mechanism for cardiac K+ channel remodelling","volume":"29","author":"Rozanski","year":"2002","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.ecl.2006.05.003_bib40","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1161\/01.CIR.0000012467.61045.87","article-title":"Adaptation and maladaptation of the heart in diabetes: Part II. potential mechanisms","volume":"105","author":"Young","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ecl.2006.05.003_bib41","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.2337\/diabetes.50.12.2809","article-title":"PPAR-alpha-null mice are protected from high-fat diet-induced insulin resistance","volume":"50","author":"Guerre-Millo","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.ecl.2006.05.003_bib42","doi-asserted-by":"crossref","first-page":"35799","DOI":"10.1074\/jbc.M006001200","article-title":"Glucose down-regulates the expression of the peroxisome proliferator-activated receptor alpha gene in the pancreatic beta -cell","volume":"275","author":"Roduit","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ecl.2006.05.003_bib43","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1172\/JCI0214080","article-title":"The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus","volume":"109","author":"Finck","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ecl.2006.05.003_bib44","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1172\/JCI16751","article-title":"Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy","volume":"111","author":"Yagyu","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ecl.2006.05.003_bib45","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1073\/pnas.97.4.1784","article-title":"Lipotoxic heart disease in obese rats: implications for human obesity","volume":"97","author":"Zhou","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ecl.2006.05.003_bib46","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","article-title":"New type of cardiomyopathy associated with diabetic glomerulosclerosis","volume":"30","author":"Rubler","year":"1972","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ecl.2006.05.003_bib47","first-page":"3","article-title":"Pathobiology of the heart in experimental diabetes: immunolocalization of lipoproteins, immunoglobulin G, and advanced glycation endproducts proteins in diabetic and\/or hyperlipidemic hamster","volume":"77","author":"Sima","year":"1997","journal-title":"Lab Invest"},{"key":"10.1016\/j.ecl.2006.05.003_bib48","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1172\/JCI108843","article-title":"Evidence for cardiomyopathy in familial diabetes mellitus","volume":"60","author":"Regan","year":"1977","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ecl.2006.05.003_bib49","doi-asserted-by":"crossref","DOI":"10.1136\/hrt.2005.079350","article-title":"The relationship between myocardial perfusion and dysfunction in diabetic cardiomyopathy: a study of quantitative contrast echocardiography and strain rate imaging","author":"Moir","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.ecl.2006.05.003_bib50","first-page":"346","article-title":"Myocardial dysfunction and adrenergic innervation in patients with type 1 diabetes mellitus","volume":"13","author":"Scognamiglio","year":"2000","journal-title":"Diabetes Nutr Metab"},{"key":"10.1016\/j.ecl.2006.05.003_bib51","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0735-1097(86)80150-4","article-title":"Radionuclide assessment of left ventricular diastolic filling in diabetes mellitus with and without cardiac autonomic neuropathy","volume":"7","author":"Kahn","year":"1986","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ecl.2006.05.003_bib52","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/clc.4960230513","article-title":"Influence of autonomic neuropathy upon left ventricular dysfunction in insulin-dependent diabetic patients","volume":"23","author":"Monteagudo","year":"2000","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.ecl.2006.05.003_bib53","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0735-1097(03)00625-9","article-title":"Diastolic dysfunction is associated with altered myocardial metabolism inasymptomatic normotensive patientswith well-controlled type 2 diabetes mellitus","volume":"42","author":"Diamant","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ecl.2006.05.003_bib54","series-title":"Goodman and Gilman's the pharmacological basis of therapeutics","first-page":"734","article-title":"Renin and angiotensin","author":"Edwin","year":"1996"},{"key":"10.1016\/j.ecl.2006.05.003_bib55","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/S0735-1097(01)01683-7","volume":"38","author":"Hunt","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ecl.2006.05.003_bib56","first-page":"S49","article-title":"ADHERE (Acute Decompensated Heart Failure National Registry): rationale, design, and subject population","volume":"8","author":"Fonarow","year":"2002","journal-title":"J Card Fail"},{"key":"10.1016\/j.ecl.2006.05.003_bib57","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.2337\/diacare.24.9.1614","article-title":"Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors","volume":"24","author":"Nichols","year":"2001","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"10.1016\/j.ecl.2006.05.003_bib58","article-title":"Diabetes predicts congestive heart failure risk in the elderly","volume":"98","author":"Chae","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ecl.2006.05.003_bib59","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1161\/01.CIR.103.22.2668","article-title":"Glycemic control and heart failure among adult patients with diabetes","volume":"103","author":"Iribarren","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ecl.2006.05.003_bib60","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.2337\/diacare.26.10.2791","article-title":"Diabetes and idiopathic cardiomyopathy: a nationwide case-control study","volume":"26","author":"Bertoni","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ecl.2006.05.003_bib61","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.ecl.2006.05.003_bib62","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/clc.4960180604","article-title":"Cardiac consequences of diabetes mellitus","volume":"18","author":"Shehadeh","year":"1995","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.ecl.2006.05.003_bib63","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2337\/diacare.17.7.633","article-title":"Which left ventricular function is impaired earlier in the evolution of diabetic cardiomyopathy? An echocardiographic study of young type I diabetic patients","volume":"17","author":"Raev","year":"1994","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ecl.2006.05.003_bib64","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1067\/mhj.2001.116957","article-title":"Several factors associated with the insulin resistance syndrome are predictors of left ventricular systolic dysfunction in a male population after 20 years of follow-up","volume":"142","author":"Arnlov","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.ecl.2006.05.003_bib65","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0735-1097(03)00654-5","article-title":"Patients with early diabetic heart disease demonstrate a normal myocardial response to dobutamine","volume":"42","author":"Fang","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ecl.2006.05.003_bib66","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.289.2.194","article-title":"Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic","volume":"289","author":"Redfield","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ecl.2006.05.003_bib67","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0002-9149(97)89163-1","article-title":"Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry","volume":"77","author":"Shindler","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ecl.2006.05.003_bib68","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/1570161043385655","article-title":"Diabetic cardiomyopathy: electromechanical cellular alterations","volume":"2","author":"Casis","year":"2004","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.ecl.2006.05.003_bib69","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ecl.2006.05.003_bib70","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","author":"UKPD Study Group","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ecl.2006.05.003_bib71","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.2337\/diab.45.12.1661","article-title":"Thiazolidinediones in the treatment of insulin resistance and type II diabetes","volume":"45","author":"Saltiel","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.ecl.2006.05.003_bib72","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.2337\/diabetes.51.4.1110","article-title":"Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the Zucker fatty rat heart","volume":"51","author":"Sidell","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.ecl.2006.05.003_bib73","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1161\/01.CIR.0000054675.30348.9A","article-title":"Glitazones and heart failure: critical appraisal for the clinician","volume":"107","author":"Wang","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ecl.2006.05.003_bib74","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1007\/s001250050509","article-title":"Acute and chronic effects of troglitazone (CS-045) on isolated rat ventricular cardiomyocytes","volume":"39","author":"Bahr","year":"1996","journal-title":"Diabetologia"},{"key":"10.1016\/j.ecl.2006.05.003_bib75","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1210\/endo.139.11.6310","article-title":"The new antidiabetic drug MCC-555 acutely sensitizes insulin signaling in isolated cardiomyocytes","volume":"139","author":"Liu","year":"1998","journal-title":"Endocrinology"},{"issue":"Suppl 8A","key":"10.1016\/j.ecl.2006.05.003_bib76","doi-asserted-by":"crossref","first-page":"111S","DOI":"10.1016\/j.amjmed.2003.09.018","article-title":"Considerations for management of fluid dynamic issues associated with thiazolidinediones","volume":"115","author":"Hollenberg","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.ecl.2006.05.003_bib77","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1161\/01.CIR.0000103683.99399.7E","article-title":"Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association","volume":"108","author":"Nesto","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ecl.2006.05.003_bib78","unstructured":"Wilding J, Dargie H, Hildebrandt P, et\u00a0al. Rosiglitazone (RSG) administered to patients with type 2 diabetes (T2DM) and class I\/II congestive heart failure (CHF) does not adversely affect echocardiographic structure or function parameters. American Diabetes Association; 2005. Available at: http:\/\/scientificsession.diabetes.org. Accessed August 1, 2006."},{"key":"10.1016\/j.ecl.2006.05.003_bib79","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/01.CIR.0000154542.13412.B1","article-title":"Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study","volume":"111","author":"Masoudi","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ecl.2006.05.003_bib80","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1464-5491.1994.tb02009.x","article-title":"Is there a role for beta-blockers in hypertensive diabetic patients?","volume":"11","author":"Tse","year":"1994","journal-title":"Diabet Med"},{"key":"10.1016\/j.ecl.2006.05.003_bib81","doi-asserted-by":"crossref","first-page":"II-58","DOI":"10.1002\/j.1932-8737.1997.tb00014.x","article-title":"Potential role of angiotensin-converting enzyme inhibition in myocardial ischemia and current clinical trials","volume":"20","author":"Pepine","year":"1997","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.ecl.2006.05.003_bib82","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ecl.2006.05.003_bib83","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0140-6736(99)12323-7","article-title":"Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy","volume":"355","author":"Heart Outcomes Prevention Evaluation Study investigators","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ecl.2006.05.003_bib84","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/S0735-1097(03)00262-6","article-title":"Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials","volume":"41","author":"Shekelle","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ecl.2006.05.003_bib85","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group","volume":"317","author":"UKPD Study Group","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.ecl.2006.05.003_bib86","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1054\/jcaf.2003.31","article-title":"Survival and hospitalization in heart failure patients with or without diabetes treated with beta-blockers","volume":"9","author":"Bobbio","year":"2003","journal-title":"J Card Fail"},{"key":"10.1016\/j.ecl.2006.05.003_bib87","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0002-8703(03)00403-4","article-title":"Are beta-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials","volume":"146","author":"Haas","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.ecl.2006.05.003_bib88","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ahj.2004.05.056","article-title":"Efficacy, safety and tolerability of metoprolol CR\/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF","volume":"149","author":"Deedwania","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.ecl.2006.05.003_bib89","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group","volume":"334","author":"Packer","year":"1996","journal-title":"N Engl J\u00a0Med"},{"key":"10.1016\/j.ecl.2006.05.003_bib90","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial","volume":"353","author":"CIBIS-II investigators","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ecl.2006.05.003_bib91","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)","volume":"353","author":"MERIT-HF investigators","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ecl.2006.05.003_bib92","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","article-title":"Effect of carvedilol on survival in severe chronic heart failure","volume":"344","author":"Packer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ecl.2006.05.003_bib93","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(97)80008-6","article-title":"Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia\/New Zealand Heart Failure Research Collaborative Group","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ecl.2006.05.003_bib94","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1067\/mhj.2001.117600","article-title":"Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial","volume":"142","author":"Wedel","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.ecl.2006.05.003_bib95","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S1388-9842(01)00174-X","article-title":"Results from post-hoc analyses of the CIBIS II trial: effect of bisoprolol in high-risk patient groups with chronic heart failure","volume":"3","author":"Erdmann","year":"2001","journal-title":"Eur J Heart Fail"},{"issue":"Suppl II","key":"10.1016\/j.ecl.2006.05.003_bib96","article-title":"Should physicians avoid the use of beta-blockers in patients with heart failure who have diabetes? Results of the COPERNICUS study. Presented at the American Heart Association 74th Annual Scientific Session. Anaheim (CA), November 14, 2001","volume":"104","author":"Mohacsi","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ecl.2006.05.003_bib97","article-title":"Effect of carvedilol on LV function and mortality in diabetic vs non-diabetic patients with ischemic or nonischemic dilated cardiomyopathy. Presented at the 69th Scientific Sessions, New Orleans Convention Center. New Orleans, November 10-13, 1996","volume":"84","author":"Bristow","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ecl.2006.05.003_bib98","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2337\/diacare.14.3.203","article-title":"Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism","volume":"14","author":"Lithell","year":"1991","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ecl.2006.05.003_bib99","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1001\/jama.292.18.2227","article-title":"Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial","volume":"292","author":"Bakris","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ecl.2006.05.003_bib100","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852906000405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852906000405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:28:16Z","timestamp":1760174896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852906000405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":100,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0889852906000405"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2006.05.003","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetic Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2006.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}